ArticleJTCVS structural and endovascular2025
The perfect match: Aortic valve sizing to maximize hemodynamic performance and survival.
Article in JTCVS structural and endovascular, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Outcomes of surgical and transcatheter aortic valve replacement in patients with large and extra-large aortic annuli.JTCVS open · 2026Article
- Surgical Information Available on the Box of Cardiac Valve Prostheses Remains Inadequate.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: We assessed the value of using a size ratio of implanted valve opening diameter to native annular diameter to determine postoperative hemodynamics and survival after surgical aortic valve replacement. Methods: In total, 1519 patients from 3 trials had a preoperative computed tomography scan. A size ratio was created using the implanted valve's Ebels' prosthetic valve-derived effective diameter (ED) and the patient's computed tomography perimeter-derived native annular diameter (CTD). Restricted cubic spline curves showed the association between size ratio and hemodynamic performance. Patients were divided into 3 ratio groups: <80%, 80% to 90%, and >90%. Hemodynamic performance was evaluated yearly for 5 years. Multivariable proportional hazard regression examined the association between size ratio and 5-year survival. Results: Mean valve gradient, peak velocity, effective orifice area (EOA), indexed EOA, dimensionless velocity index, and prosthesis-patient mismatch were significantly better advancing from the 80% to the 90% groups ( Conclusions: An ED/CTD size ratio >90% is associated with optimal postoperative hemodynamic performance and improved 5-year survival. Preoperative ED/CTD ratio provides the ideal implanted valve size and helps determine if annular enlargement is necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.